[Upcoming Event] IFPMA-JPMA Collaboration on Global Health, symposium jointly hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Japan Pharmaceutical Manufacturers Association (JPMA) “Proposals for the G7 Hiroshima Summit Health Agenda—Applying Lessons Learned from COVID-19 and Driving Progress Towards SDG3: a Roadmap for Action” (May 12, 2023; Iino Hall & Conference Center, Chiyoda Ward, Tokyo)
date : 4/27/2023
Tags: Global Health
On May 12, 2023, a symposium titled “Proposals for the G7 Hiroshima Summit Health Agenda—Applying Lessons Learned from COVID-19 and Driving Progress Towards SDG3: a Roadmap for Action” will be jointly hosted by the IFPMA and the JPMA, and HGPI Senior Manager, Prof. Haruka Sakamoto, will be facilitating the event.
[Event Overview]
- Date & Time: Friday, May 12, 2023; 16:30 – 18:30 JST
- Format: Held in hybrid format with Zoom webinar
- Venue: Iino Hall & Conference Center, Room A (4F Iino Building) 2-1-1 Uchisaiwaicho, Chiyoda Ward, Tokyo
- Language: Japanese, English (Japanese-English simultaneous interpretation provided.)
- Admission: Free
- Secretariat: IFPMA- JPMA Symposium Secretariat (International Department, Oscar Japan Co., Ltd.)
- Capacity: On-site participation: 50 pers./Online participation 400 pers. (first-come-first-served basis)
For registration or more details, please click here
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-26
[Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
-
2024-05-01
[Registration Open] The Global Health Education Program (G-HEP) 2024 (May 1, 2024)
-
2024-05-02
[Announcement] Recruitment of the Health Policy Academy the 13th Session